Parenteral Packaging Market is growing constantly at a CAGR of 6.1%, North America leads the market with 39% market share.

The global parenteral packaging market was valued at USD 25.6 billion in 2024 and is estimated to grow at a CAGR of 6.1% from 2025 to 2034. One of the most important factors boosting the market is the high demand for ready-to-use (RTU) solutions. These solutions offer several other advantages, including lower production costs, reduced chances of battery and contamination, and improved stability of the drug.

Parenteral packaging refers to specialized containers and delivery systems designed for sterile injectable drugs, ensuring product integrity, safety, and stability, while preventing contamination during storage, transport, and administration in healthcare settings.

DataM Intelligence unveils its latest report on the " Parenteral packaging Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/parenteral-packaging-market?prtk

United States: Key Industry Developments (2025)

✅ October 2025: Terumo Pharmaceutical Solutions (TPS) launched a ready‐to‐fill polymer syringe designed for high‐volume biotech drugs, improving ease‐of‐use and expanding options for complex injectable therapies in pharmaceutical packaging.

✅ August 2025: The U.S. parenteral packaging sector continued robust growth with overall market expansion driven by demand for sterile, high‐quality injectable packaging solutions for biologics and vaccines, as companies invest in advanced vial, syringe, and cold chain formats.

✅ March 2025: SGD Pharma introduced new RTD (ready‐to‐dispense) sterile 100 ml molded glass vials, enhancing stability and convenience for parenteral drug manufacturers and improving supply chain handling in the U.S. pharmaceutical packaging landscape.

Japan: Key Industry Developments (2025)

✅ August 2025: Japanese pharmaceutical packaging manufacturers strengthened adoption of pre‐filled syringes and advanced polymer packaging systems, reflecting rising demand for user‐friendly injectable formats and reinforcing Japan's commitment to quality and patient‐centric solutions.

✅ July 2025: Japan's parenteral packaging market saw increased R&D investment in polymer‐based and ready‐to‐use packaging materials to support biologics and vaccine distribution, aligning with global quality standards and enhancing local manufacturing capabilities.

📌 Parenteral packaging Market 2025-26 M&A Deals

→ In October 2025, West Pharmaceutical Services, Inc. entered into a strategic partnership with a leading biotechnology firm to co‐develop next‐generation drug delivery systems aimed at advancing parenteral packaging innovation.

→ In July 2025, SCHOTT AG opened a new R&D center for parenteral packaging innovation, supporting advances in sterile packaging materials.

→ In June 2025, Gerresheimer AG acquired a minority stake in a smart packaging startup to accelerate digital‐enabled parenteral packaging solutions and integration of advanced technologies into primary packaging offerings.

→ In March 2025, a private equity consortium including Warburg Pincus and KKR submitted a non‐binding bid to acquire Gerresheimer AG (a major pharmaceutical and parenteral packaging player), valuing the company at roughly €3.1 billion ($3.37 billion) as part of early acquisition discussions though the bid remained preliminary and the sale was not concluded.

Parenteral packaging Market Drivers:-
⏩ One of the most powerful narratives shaping the parenteral packaging market is the dramatic rise in injectable drugs and biologic therapies. In recent years, more than 58% of newly approved drugs have been biologic or injectable in nature, requiring specialized sterile packaging such as vials, ampoules, prefilled syringes, and cartridges.

⏩ Biologicsincluding monoclonal antibodies, mRNA‐based treatments, and advanced cancer therapiesdemand high‐purity glass and inert polymers to maintain stability and prevent drug degradation. This elevated demand has translated directly into growth in parenteral packaging units worldwide, with over 38 billion parenteral containers used globally in 2023 alone.

⏩ A compelling driver continues to be the global increase in chronic conditionssuch as diabetes, cancer, cardiovascular diseases, and autoimmune disorderswhich rely heavily on injectable medications for treatment and management.

⏩ The shift toward self‐administration of injectable drugs-particularly for chronic conditions like diabetes and rheumatoid arthritis-has fueled uptake of user‐friendly formats such as prefilled syringes and cartridges. These formats not only reduce clinical burden but also enhance patient compliance and safety.

⏩ This trend amplifies demand for advanced parenteral packaging solutions that are easy to handle outside of hospital settings, with an emphasis on tamper‐evidence, accuracy, and ergonomic design.

⏩ The biopharmaceutical sector-once a niche-now dominates new drug pipelines. These complex therapies require robust packaging materials that protect sensitive molecules and ensure cold chain integrity; as a result, parenteral packaging demand rises in step with biopharmaceutical output.

⏩ Additionally, global vaccination campaigns and widespread immunization initiatives continue to generate significant volumes of sterile vials and syringes. The COVID‐19 pandemic illustrated this connection clearly: the global demand for specialized packaging surged with the rollout of vaccines and emergency therapeutics.

⏩ Smart features like RFID tags and temperature‐sensitive indicators are being integrated to support traceability and cold chain assurance.

⏩ Advanced materials such as COP and high‐barrier polymers are replacing traditional glass in select applications, offering advantages in weight, break resistance, and design flexibility.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=parenteral-packaging-market?prtk

Parenteral packaging Major Players:-

Bormioli Pharma S.p.A, UFP Technologies, Inc., Schott AG, UDG Healthcare plc, Gerresheimer AG, Becton, Dickinson and Company, Catalent, Inc., Stevanato Group S.p.A., Baxter International Inc. among others.

Key players highlights:-

Schott AG - German leader in borosilicate glass vials and injectable packaging with strong global footprint; renowned for ultra‐pure glass solutions. Estimated 12-26 % share in glass parenteral packaging.

Gerresheimer AG - Major German supplier of glass and plastic primary packaging for injectables; expanded capabilities with Bormioli Pharma acquisition. Holds 13.5 % market share.

Becton, Dickinson and Company (BD) - US medical technology giant with significant presence in prefillable syringes and safety systems for injectables, part of leading parenteral tier.

Stevanato Group S.p.A. - Italian expert in glass primary packaging (vials, cartridges, syringes) and ready‐to‐fill formats; recognized as a strong second‐tier player.

Catalent, Inc. - US‐based pharma services provider offering parenteral packaging and drug delivery solutions, supporting high‐volume injectable manufacturing.

Regional Highlights
North America
• Holds the largest global share of 39% of the parenteral packaging market.
• Growth driven by strong healthcare infrastructure, high biologics/vaccine demand, and major pharmaceutical manufacturing.
• Ongoing investments in advanced packaging tech and regulatory quality standards support expansion.

Europe
• Accounts for 29% of the global market share.
• Market development supported by robust pharma sector, strict regulations, and sustainability focus.
• Germany, France, and the U.K. are leading contributors with increased adoption of advanced formats.

Asia‐Pacific
• Holds 27% share and is one of the fastest‐growing regions.
• Growth fueled by rising healthcare expenditure, expanding injectable drug production, and local capacity build‐up.
• China, India, and Japan are key markets driving regional expansion.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/parenteral-packaging-market?prtk

Parenteral packaging market segmentation :

The Parenteral Packaging Market is segmented based on product type, material, and packaging format. By product type, it includes pre-filled syringes, injectables, vials, ampoules, cartridges, and others. By material, packaging is classified into glass and plastic. By packaging type, it is divided into small volume parenterals (SVP) and large volume parenterals (LVP), catering to different drug delivery needs and volumes.

Q: What are the key segments in the Parenteral Packaging Market?
A: Segments include product type (vials, ampoules, pre-filled syringes, cartridges), material type (glass, plastic), and packaging type (SVP, LVP).

Q: Which regions dominate the Parenteral Packaging Market?
A: North America and Europe lead in market share, while Asia-Pacific shows the fastest growth due to rising biologics and injectables demand.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.